ITCHOTELS evidence report
Evidence date: 2026-10-01. Research observations only.
What can I do with this stock?
Evaluated 2026-10-02T01:37:53.224812+00:00. Closed-session evidence: 2026-10-01. This is a timestamped assessment, not a live trading feed.
Strategy evidence, instrument feasibility and portfolio suitability are separate. Portfolio suitability has not been assessed.
Today: intraday
Evidence unavailable
No current intraday signal and observed quote supplied; daily bars cannot establish a live setup.
- No current intraday signal and observed quote supplied; daily bars cannot establish a live setup.
Next week: five trading sessions
No qualifying opportunity
No candidate with a primary five-session horizon in the coherent source run.
- No candidate with a primary five-session horizon in the coherent source run.
Long term: one to three years
Research only
A financial screen alone does not establish an investment recommendation.
- A current, source-backed thesis and valuation review is required.
Investment evidence
- Statement coverage
- FULL_STATEMENTS
- Financial source retrieved
- 2026-09-14T13:56:17.697003+00:00
Metrics
- latest_annual_period
- 2026-03-31
- revenue
- 41091200000.0
- net_income
- 8168900000.0
- operating_cash_flow
- 11098500000.0
- free_cash_flow
- 6995900000.0
- total_assets
- 134845900000.0
- total_liabilities
- 17860800000.0
- total_equity
- 116578200000.0
- cash
- 352100000.0
- total_debt
- 741900000.0
- revenue_growth
- 0.16542347115313705
- earnings_growth
- 0.28731266842113556
- net_margin
- 0.19879925628845105
- roe
- 0.07007227766426313
- debt_to_equity
- 0.0063639685635907915
- cash_conversion
- 1.3586284567077576
- free_cash_flow_margin
- 0.17025299820886225
- trailing_pe
- 39.6284
- forward_pe
- 0.0
- peg_ratio
- Not supplied
- price_to_book
- 2.9128
- dividend_yield
- 0.0
Other positional research
No qualifying opportunity
No candidate at another positional horizon in the coherent source run.
- No candidate at another positional horizon in the coherent source run.
Decision provenance and limitations
- Decision ID
- decision-19371869d0f426ef366ad776264941de92757b8af2652bab22f7b16bd31b7ddf
- Policy
- stock-decisions-v1
- Evidence bundle hash
- bfa9ec68fcebe04ebe09021a46e1b99c602aeaaef8668de6623922b3693acdb1
- market-brief: a7de4d64fedac164d48cdfb9b4081a4666d7f797f7d9c58da304b329b3a61d3c
- validation-registry: b1069587129bfc64a703cdf8322d0294692585b7d67f5472593e4164bbb0c3bc
- financial-statements: 9192c7521be7d3892d1733d3e6c4a497a1c4117a55c6d3062b42081e2733d474
- daily-price: 9d65c9ab9f68bcb6be449dabbbba4411566db54e57db56a38eb2e03dc21fd607
- Conditional research decisions are not orders or personalized position sizes.
- Scenario payoffs are assumptions, not probabilities or expected returns.
- A stop price does not guarantee a maximum loss through a gap or illiquidity.
Download the decision evidence as JSON
Numerical report available. Evidence briefing is queued or awaiting retry.
Cached observations and evidence limits
- Price source verification: REPAIRED.
- The cached closing price on 2026-10-01 was INR 158.51.
- The trailing 5-session price return was -3.35%.
- The trailing 20-session price return was -0.08%.
- The trailing 60-session price return was -10.76%.
- The trailing 250-session price return was -30.39%.
- Average cached traded value over twenty sessions was INR 273,143,598.
- The closing price was -30.84% below its highest close in the available trailing year.
- Fundamental coverage is FULL_STATEMENTS; retrieved 2026-09-14T13:56:17.697003+00:00 from EODHD.
- The cached financial metric latest annual period is 2026-03-31.
- The cached financial metric revenue growth is 0.16542347115313705.
- The cached financial metric net margin is 0.19879925628845105.
- The cached financial metric roe is 0.07007227766426313.
- The cached financial metric debt to equity is 0.0063639685635907915.
- The cached financial metric cash conversion is 1.3586284567077576.
- The cached financial metric free cash flow margin is 0.17025299820886225.
- Historical observations do not establish future returns. No verified current news or catalyst evidence is supplied.